Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus dobutamine after cardiac surgery in low cardiac output syndrome
2014-001461-27Phase 4Active
- Sponsor
- Fundación IMABIS
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan and dobutamine in low cardiac output syndrome (LCOS) (2 arms), sponsored by Fundación IMABIS. Primary endpoint: Renal and neurological organ preservation. Started Oct 2014; status: active.
02
Drugs
levosimendandobutamine
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on 2014-001461-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001461-27.